What are the indications and safety precautions for performing a transesophageal echocardiogram (TEE) in a pregnant patient with cardiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TEE in Pregnant Patients with Cardiac Disease

Transesophageal echocardiography is relatively safe during pregnancy and should be performed when clinically indicated, though it is rarely required since transthoracic echocardiography is the preferred first-line imaging modality. 1

Primary Imaging Strategy

  • Transthoracic echocardiography (TTE) is the preferred screening method to assess cardiac function in pregnant patients because it involves no radiation exposure, is easy to perform, and can be repeated as often as needed. 1
  • TTE should be the initial diagnostic approach for evaluating cardiac structure, function, valvular anatomy, and hemodynamics in pregnant women with known or suspected heart disease. 2

Indications for TEE During Pregnancy

TEE should only be performed when TTE provides insufficient diagnostic information for complete assessment of complex cardiac conditions. 1

Specific clinical scenarios where TEE may be indicated include:

  • Complex congenital heart disease requiring detailed anatomic assessment that cannot be adequately visualized by TTE. 1
  • Prosthetic valve evaluation when TTE is inadequate for assessing valve function or detecting complications such as endocarditis. 3
  • Suspected endocarditis with inadequate TTE visualization, particularly for detecting vegetations, abscesses, or perivalvular complications. 3
  • Aortic pathology including suspected aortic dissection when TTE and MRI are insufficient or unavailable. 1
  • Cardioembolic source evaluation when TTE fails to identify the etiology in patients with stroke or systemic embolism. 3

Safety Profile and Precautions

TEE is relatively safe during pregnancy with an overall complication rate of approximately 0.2% in the general population. 4

Critical Safety Considerations:

  • Risk of aspiration is heightened in pregnancy due to delayed gastric emptying, increased gastric acidity, and decreased lower esophageal sphincter tone. 1
  • Fetal monitoring should be performed if sedation is used during the procedure. 1
  • Sudden increases in intra-abdominal pressure during probe insertion or manipulation pose theoretical risks in pregnancy. 1

Absolute Contraindications:

  • Active esophageal pathology (stricture, tumor, diverticulum, perforation). 3
  • Recent esophageal surgery. 3
  • History of esophageal perforation. 3

Relative Contraindications Requiring Risk-Benefit Assessment:

  • Esophageal varices (particularly relevant in pregnant patients with portal hypertension). 3
  • Active upper gastrointestinal bleeding. 3
  • Severe cervical spine disease limiting neck flexion. 5

Procedural Modifications for Pregnancy

  • Minimize or avoid sedation when possible to reduce aspiration risk and eliminate need for fetal monitoring. 1
  • If sedation is necessary, use the lowest effective dose and maintain continuous fetal heart rate monitoring. 1
  • Ensure adequate NPO status (nothing by mouth for at least 6-8 hours) to minimize aspiration risk. 5
  • Position patient in left lateral decubitus position when feasible to avoid aortocaval compression in later pregnancy. 1

Alternative Advanced Imaging When TEE is Contraindicated

MRI without gadolinium contrast is the preferred alternative when TEE cannot be performed and TTE is insufficient. 1

  • MRI is probably safe during pregnancy, especially after the first trimester. 1
  • Gadolinium-based contrast must be avoided as it crosses the placental barrier with unknown long-term fetal effects. 1
  • CT should be avoided due to radiation exposure unless absolutely necessary for life-threatening conditions like pulmonary embolism. 1

Common Pitfalls to Avoid

  • Do not delay clinically indicated TEE due to pregnancy alone—the maternal benefit of accurate diagnosis typically outweighs the minimal procedural risk. 1
  • Do not perform TEE as a screening test in pregnant patients when TTE can provide adequate diagnostic information. 1
  • Do not use TEE for endocarditis evaluation in low pre-test probability scenarios (transient fever, negative blood cultures, known alternative infection source). 1
  • Ensure experienced operators perform the procedure to minimize complications and procedure time. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Echocardiography in Pregnancy: Part 2.

Current cardiology reports, 2016

Research

Transesophageal echocardiography.

Mayo Clinic proceedings, 1994

Research

Safety of transesophageal echocardiography.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.